Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIGF-I/rhIGFBP-3 in children and adolescents with growth hormone insensitivity syndrome
2004-000644-25Phase 2Completed
- Sponsor
- Insmed Incorporated
- Start
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Premiplex in growth hormone insensitivity (GHIS) and Laron syndrome (LS), sponsored by Insmed Incorporated. Primary endpoint: Change in height velocity from baseline. Started Jun 2004; status: completed.
02
Drugs
Premiplex
03
Conditions
growth hormone insensitivity (GHIS)Laron syndrome (LS)
Beyond the preview
Go deeper on 2004-000644-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000644-25.